Brano

Advancing novel therapies for heart failure

Brano was founded in 2026, is headquartered in Singapore, Singapore, lists 1–10 employees, and has $6.8M in recorded funding across 1 round.

Headquarters
Singapore
Employees
1–10
Founded
2026
Business Model
B2B
Total Funding
$6.8M
Last Round
$6.8M SeedMay 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Brano Therapeutics is a biotechnology spin-off from Duke-NUS Medical School in Singapore, focused on developing novel treatments for heart failure, including Heart Failure with preserved Ejection Fraction (HFpEF). The company is built on research identifying a distinct metabolic abnormality in failing hearts — where the heart becomes less efficient at processing key nutrients — and is developing compounds that restore metabolic regulation to reduce heart stiffness and improve cardiac function. Backed by Trinity Innovation Bioventure Singapore (TIBS), SEEDS (SG Growth Capital), SGInnovate, and Duke-NUS' LIVE Ventures, Brano aims to advance its lead program into clinical trials by 2029.

Summary

Brano is a Biotech company based in Singapore, Singapore, founded in 2026. It lists 1–10 employees. It has raised $6.8M in total across 1 round, most recently a $6.8M Seed round in May 2026. Investors include Trinity Innovation Bioventure Singapore and Enterprise Singapore Seeds Capital.

Funding History

SeedMay 2026
$6.8M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Brano on Indexed.vc
<a href="https://indexed.vc/companies/brano"><img src="https://indexed.vc/api/badge/company/brano" alt="Brano on Indexed.vc" width="260" height="76" /></a>